Annals of Emergency Medicine
Volume 28, Issue 5 , Pages 515-519, November 1996

Interrater Agreement in the Measurement of QRS Interval in Tricyclic Antidepressant Overdose: Implications for Monitoring and Research☆☆

Received 15 January 1996; accepted 5 July 1996.

Abstract 

Study objective: To assess interobserver agreement when experienced clinicians measure QRS-interval duration in tricyclic antidepressant (TCA) overdose. Methods: We studied the admission ECGs of 231 patients with TCA poisoning. Three of the authors, with experience in the management of TCA poisoning, independently measured QRS intervals manually. Each rater was blinded to patient outcome and the measurements made by the other raters. Our main outcome measure was agreement among raters, particularly as it applies to clinically used QRS cutoff points for the determination of treatment and disposition. Results: Agreement on the measurement of QRS intervals was good (intraclass correlation coefficient, .60; 95% confidence interval [CI], .53 to .66) for transformed data and .82 (95% CI, .78 to .85) for raw data. When assigning patients to categories of QRS interval, the raters agreed on 169 of 231 patients (73%) (weighted κ=.83; P<.0001). However, the raters did not agree unanimously on whether the QRS interval was less than 100 milliseconds or 100 milliseconds or greater in 45 of 231 of patients (19.5%) (κ=.69; P<.0001). Conclusion: Reliance on the manually measured QRS interval to determine management in TCA poisoning is not justified because of substantial observer variation in the determination of whether the interval falls below the clinical cutoff point of 100 milliseconds. Agreement is sufficient to make the measurements useful as part of the overall assessment of toxicity.

[Buckley NA, O'Connell DL, Whyte IM, Dawson AH: Interrater agreement in the measurement of QRS interval in tricyclic antidepressant overdose: Implications for monitoring and research. Ann Emerg Med November 1996;28:515-519.]

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 From the Discipline of Clinical Pharmacology, University of Newcastle*; and the Department of Clinical Toxicology and Pharmacology, newcastle Mater Misericordiae Hospital, Newcastle Australia

☆☆ Address for reprints: Nicholas A Buckley, BMed, Mater Misericordiae Hospital, Newcastle, NSW 2298, Australia

 Reprint no. 47/1/77014

PII: S0196-0644(96)70115-4

Annals of Emergency Medicine
Volume 28, Issue 5 , Pages 515-519, November 1996